Amneal Pharmaceuticals Inc (N:AMRX)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for AMRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Todisco Joseph Direct Ownership Class A Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -20,096  
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,311 $5.13
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 20,096  
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -27,614  
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,188 $4.72
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 27,614  
Dec 17/19 Dec 14/19 Yanai Shlomo Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 7,522  
Dec 17/19 Dec 14/19 Yanai Shlomo Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 28,506  
Dec 17/19 Dec 14/19 George Jeffrey P. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 28,506  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for AMRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Todisco Joseph Direct Ownership Class A Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -20,096  
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,311 $5.13
Jan 23/20 Jan 22/20 Branning Todd P. Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 20,096  
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -27,614  
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,188 $4.72
Jan 6/20 Jan 3/20 Buchen David A Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 27,614  
Dec 17/19 Dec 14/19 Yanai Shlomo Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 7,522  
Dec 17/19 Dec 14/19 Yanai Shlomo Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 28,506  
Dec 17/19 Dec 14/19 George Jeffrey P. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 28,506  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $AMRX

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
BridgeBio Pharma (OQ:BBIO)
Arvinas (OQ:ARVN)